WAVE LIFE SCIENCES LTD. Deferred Income Tax Expense (Benefit)
WAVE LIFE SCIENCES LTD. (WVE) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-26
- WAVE LIFE SCIENCES LTD. deferred income tax expense (benefit) for fiscal 2025 was $0.00.
- WAVE LIFE SCIENCES LTD. deferred income tax expense (benefit) for fiscal 2024 was $0.00.
- WAVE LIFE SCIENCES LTD. deferred income tax expense (benefit) for fiscal 2023 was $0.00.
- WAVE LIFE SCIENCES LTD. deferred income tax expense (benefit) for fiscal 2017 was $908.00K.
| Period end | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | |
| 2017-12-31 | $908.00K 10-K · filed 2020-03-02 | $774.00K 10-K · filed 2018-03-12 |
| 2016-12-31 | -$698.00K 10-K · filed 2019-03-01 | -$564.00K 10-K · filed 2017-03-16 |
| 2015-12-31 | $36.00K 10-K · filed 2018-03-12 | |
| 2014-12-31 | $84.00K 10-K · filed 2017-03-16 | |
| 2013-12-31 | -$330.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |